IRIS
CAROTENUTO, ALFONSO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.204
NA - Nord America 7.124
EU - Europa 5.164
SA - Sud America 825
Continente sconosciuto - Info sul continente non disponibili 351
AF - Africa 189
OC - Oceania 7
Totale 20.864
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.810
SG - Singapore 3.173
RU - Federazione Russa 2.303
CN - Cina 1.414
VN - Vietnam 1.277
IT - Italia 1.037
BR - Brasile 656
HK - Hong Kong 547
DE - Germania 291
FR - Francia 273
IE - Irlanda 230
FI - Finlandia 227
NL - Olanda 198
UA - Ucraina 169
CA - Canada 166
GB - Regno Unito 155
IN - India 137
JP - Giappone 134
BD - Bangladesh 108
SE - Svezia 96
MX - Messico 65
AR - Argentina 63
CI - Costa d'Avorio 55
KR - Corea 51
IQ - Iraq 49
PH - Filippine 45
TH - Thailandia 40
ZA - Sudafrica 40
PL - Polonia 39
TR - Turchia 38
ES - Italia 37
ID - Indonesia 31
TW - Taiwan 25
EC - Ecuador 22
BE - Belgio 20
CO - Colombia 20
JM - Giamaica 20
AT - Austria 19
PK - Pakistan 19
VE - Venezuela 15
MA - Marocco 14
PY - Paraguay 14
CR - Costa Rica 13
IL - Israele 13
EG - Egitto 12
CL - Cile 11
LT - Lituania 11
MY - Malesia 11
NP - Nepal 11
JO - Giordania 10
PE - Perù 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
UZ - Uzbekistan 10
BG - Bulgaria 9
KE - Kenya 9
SA - Arabia Saudita 9
DZ - Algeria 8
IR - Iran 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
HN - Honduras 7
KZ - Kazakistan 7
SN - Senegal 7
GT - Guatemala 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
GR - Grecia 5
NG - Nigeria 5
OM - Oman 5
RO - Romania 5
CH - Svizzera 4
MD - Moldavia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
GA - Gabon 3
LV - Lettonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
BZ - Belize 2
CD - Congo 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
EE - Estonia 2
HR - Croazia 2
LU - Lussemburgo 2
MG - Madagascar 2
Totale 20.470
Salva come PNG Salva come JPEG
Città #
Singapore 1.431
San Jose 1.155
Chandler 581
Moscow 560
Ashburn 528
Hong Kong 524
Beijing 434
Ho Chi Minh City 359
Santa Clara 327
Hanoi 288
Naples 274
Dallas 200
Amsterdam 186
Hefei 183
Los Angeles 178
Lauterbourg 175
Millbury 173
Princeton 168
Jacksonville 166
Council Bluffs 153
Boston 143
The Dalles 140
Nanjing 131
Napoli 114
Tokyo 107
New York 94
Buffalo 86
São Paulo 80
Munich 74
Ottawa 71
Wilmington 66
Da Nang 63
Des Moines 62
Redondo Beach 57
Woodbridge 56
Brooklyn 54
Haiphong 47
Ann Arbor 46
Houston 45
Seattle 44
Phoenix 39
Denver 37
Nanchang 37
Rome 37
Turku 37
Warsaw 37
Orem 36
Chicago 35
Milan 35
Frankfurt am Main 34
Seoul 33
Mexico City 32
Toronto 31
Biên Hòa 30
Shenyang 30
Montreal 29
Atlanta 27
Helsinki 27
Tianjin 25
Hebei 24
Nuremberg 24
Poplar 24
Rio de Janeiro 24
Bangkok 23
Chennai 23
North Bergen 23
Falls Church 21
Stockholm 21
Falkenstein 20
San Francisco 20
Washington 20
Baghdad 19
London 19
Augusta 18
Bologna 18
Changsha 18
Columbus 18
Jiaxing 18
Boardman 16
Charlotte 16
Kronberg 16
Hải Dương 15
Ninh Bình 15
Norwalk 15
Dong Ket 14
Florence 14
Hangzhou 14
Johannesburg 14
Lawrence 14
Ankara 13
Dublin 13
Düsseldorf 13
Guangzhou 13
Kingston 13
Manchester 13
Memphis 13
Belo Horizonte 12
Brasília 12
Pune 12
Brussels 11
Totale 10.947
Salva come PNG Salva come JPEG
Nome #
" Molecular Modelingof the Urotensin-II receptor Complex" 245
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 242
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 205
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 199
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 190
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 180
Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists 175
A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study 175
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 173
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 168
Unraveling the active conformation of urotensin II 162
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 162
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 160
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 158
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 157
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 156
Discovery of New Potent Ligands at Human Urotensin-II Receptor 156
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 153
Monitoring the effect of antagonist on P53-MDM2 interaction with NMR spectroscopy. Recent results 151
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 146
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 146
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 145
In vitro evaluation of tumor targeting ability of a parenteral enoxaparin-coated self-emulsifying drug delivery system 144
Deepening bis-(thio)carbohydrazones conformational dynamics and hydrogen bond interactions in a non-protic solvent: DFT, molecular dynamics, NMR, and Raman investigations 143
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 140
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 140
Visible Light-promoted C(sp3)-H α-Carbamoylation of Cyclic Ethers with Isocyanides 138
D-Amino Acids Containing Temporin L Analogues 138
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 138
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 136
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 134
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule 132
Synthesis and characterization of bis-triazolyl-pyridine derivatives as noncanonical DNA-interacting compounds 131
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 130
Identification of a Novel p53 Modulator Endowed with Antitumoural and Antibacterial Activity through a Scaffold Repurposing Approach 130
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 130
Host Defense Peptide-derived Privileged Scaffolds for Anti-infective Drug Discovery 130
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 130
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 129
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 129
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 129
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 129
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 128
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 128
Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis 126
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 125
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands 124
A novel β-hairpin peptide derived from the ARC repressor selectively interacts with the major groove of B-DNA 124
Photomicellar Catalyzed Synthesis of Amides from Isocyanides: Optimization, Scope, and NMR Studies of Photocatalyst/Surfactant Interactions 123
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 123
SOLUTION STRUCTURE OF MONOMERIC BOVINE SEMINAL RIBONUCLEASE 122
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 122
A proteomic approach to characterize a native antigen involved in autoantibody response in multiple sclerosis by a structure-based designed glycopeptide 122
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 121
Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors 121
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 121
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 121
Urantide Conformation and Interaction with the Urotensin-II Receptor 120
Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds 120
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 119
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human TG2 119
New Anticancer Agents Mimicking Protein Recognition Motifs. 119
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 119
1H and 15N sequential assignment and secondary structure of the monomeric N67D mutant of bovine seminal ribonuclease 118
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 118
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity. 118
Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor 117
Development of Cyclic Peptide Inhibitors of GRK2 117
Morphicetin analogues containing a new β-turn thiazolidine mimetic 115
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 115
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 115
Sar Study Of P5u And Urantide Analogues Modified At Position 9 115
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 115
A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients 114
A novel route to synthesize Freidinger lactams by microwave irradiation 114
Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope 113
Development of Antiviral Fusion Inhibitors: Short Modified Peptides Derived from the Transmembrane Glycoprotein of Feline Immunodeficiency Virus 112
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents 112
Stereostructures of new bioactive sesterterpenes isolated from the Caribbean sponge Cacospongia cf. linteiformis 112
Nuovi peptidi e peptidomimetici come agenti potenti e mirati nella prevenzione e nel trattamento dell’invasione e metastasi tumorali 111
3D structure of monomeric bovine seminal ribonuclease by heteronuclear NMR 110
Conformational Properties of a Peptide-Bridge between Tubulin and Plasma Membrane 110
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design 109
Introduction of constrained Trp analogs in RW9 modulates structure and partition in membrane models 109
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 108
Solution structure of monomeric bovine seminal ribonuclease 107
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 106
Unraveling the active conformation of urotensin II 106
STRUCTURAL STUDIES OF GLUTEN - PEPTIDE ANALOGS 103
UROTENSIN-II PEPTIDE AGONISTS AND ANTAGONISTS: A COMPREHENSIVE SAR STUDY 103
Synthesis, in vitro, and in cell studies of a new series of [Indoline-3,2'-thiazolidine]-based p53 modulators. 102
Synthesis of a Dicarba-Analog of Octreotide Keeping the Type II Beta-Turn of the Pharmacophore in Water Solution 101
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 101
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 101
UT RECEPTOR LIGANDS. SWITCHING FROM AGONIST TO ANTAGONIST ACTIVITY 100
Microwave-Assisted Solid Phase Synthesis of Backbone Cyclic Glycopeptide Libraries 98
A New, Potent Urotensin II Receptor Peptide Agonist Containing a Pen Residue at the Disulfide Bridge 97
Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin II Lactam analogues 97
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 97
"Urotensin-II (U-II) analogues containing modifications at disulfide bridge Synthesis, biological and conformational studies" 96
Totale 13.063
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022997 0 0 12 26 19 21 16 27 232 80 121 443
2022/20231.350 197 102 54 127 150 148 9 121 189 169 61 23
2023/2024985 55 138 171 56 64 93 15 126 13 16 172 66
2024/20255.222 253 305 56 73 83 309 506 327 472 571 1.805 462
2025/20269.537 1.101 747 1.043 917 1.495 393 1.170 517 1.107 618 248 181
2026/2027735 180 347 208 0 0 0 0 0 0 0 0 0
Totale 20.864